CEO Opening Sam Altman double on retro biosciences, startup biotechnology based on San Francisco who wants to manifest 10 years of life more than a healthy human age. Altman before providing all seed round retro bioscience $ 180 million. Currently, the start of raising a series A $ 1 billion incorporated with altman, financial financial reports. Retro biosciences, who said will begin testing drugs that targeted diseases like Alzheimer’s, recently trained the model with the opening of the ordinary cells into Stem cells. CEO Joe Betts-Lacroix tells Ft if they want to move quickly by finding and develop medicine “in the 2020.” Startup is joined the long-life-based efforts, including $ 3 billion in 2022 supported by Jeff Bezos, and Biotechnology Unity, supported by Bezos and Peter Thiete.
